Innovation Vision Products, Inc, New Castle, DE, USA.
Am J Ther. 2012 Mar;19(2):e69-89. doi: 10.1097/MJT.0b013e3181e71fb7.
Accumulation of molecular damage and increased molecular heterogeneity are hallmarks of photoaged skin and pathogenesis of human cutaneous disease. Growing evidence demonstrates the ability of molecular chaperone proteins and of pharmacologic chaperones to decrease the environmental stress and ameliorate the oxidation stress-related and glycation disease phenotypes, suggesting that the field of chaperone therapy might hold novel treatments for skin diseases and aging. In this review, we examine the evidence suggesting a role for molecular chaperone proteins in the skin and their inducer and protecting agents: pharmacologic chaperone imidazole dipeptide-based agents (carcinine and related compounds) in cosmetics and dermatology. Furthermore, we discuss the use of chaperone therapy for the treatment of skin photoaging diseases and other skin pathologies that have a component of increased glycation and/or free radical-induced oxidation in their genesis. We examine biologic activities of molecular and pharmacologic chaperones, including strategies for identifying potential chaperone compounds and for experimentally demonstrating chaperone activity in in vitro and in vivo models of human skin disease. This allows the protein to function and traffic to the appropriate location in the skin, thereby increasing protein activity and cellular function and reducing stress on skin cells. The benefits of imidazole dipeptide antioxidants with transglycating activity (such as carcinine) in skin care are that they help protect and repair cell membrane damage and help retain youthful, younger-looking skin. All skin types will benefit from daily, topical application of pharmacologic chaperone antioxidants, anti-irritants, in combination with water-binding protein agents that work to mimic the structure and function of healthy skin. General strategies are presented addressing ground techniques to improve absorption of usually active chaperone proteins and dipeptide compounds, include encapsulation into hydrophobic carriers, a combination with penetration enhancers, active electrical transport, or chemical modification to increase hydrophobicity.
分子损伤的积累和分子异质性的增加是光老化皮肤的标志,也是人类皮肤疾病发病机制的标志。越来越多的证据表明,分子伴侣蛋白和药理学伴侣能够降低环境应激,改善与氧化应激相关的和糖基化疾病表型,这表明伴侣治疗领域可能为皮肤疾病和衰老提供新的治疗方法。在这篇综述中,我们研究了分子伴侣蛋白在皮肤中的作用及其诱导剂和保护剂的证据:基于咪唑二肽的药理学伴侣(精胺和相关化合物)在化妆品和皮肤病学中的应用。此外,我们还讨论了使用伴侣治疗来治疗皮肤光老化疾病和其他具有糖基化和/或自由基诱导氧化成分的皮肤病理学。我们研究了分子伴侣和药理学伴侣的生物学活性,包括鉴定潜在伴侣化合物的策略和在体外和体内人类皮肤疾病模型中实验证明伴侣活性的策略。这使得蛋白质能够在适当的位置发挥功能和运输,从而提高蛋白质活性和细胞功能,减轻皮肤细胞的应激。具有转糖基活性(如精胺)的咪唑二肽抗氧化剂在皮肤护理中的益处在于,它们有助于保护和修复细胞膜损伤,并有助于保持年轻、更年轻的皮肤外观。所有类型的皮肤都将受益于每天局部应用药理学伴侣抗氧化剂、抗刺激剂,结合具有结合水蛋白的制剂,以模拟健康皮肤的结构和功能。提出了一般性策略,以改善通常具有活性的伴侣蛋白和二肽化合物的吸收,包括封装到疏水性载体中、与渗透增强剂结合、主动电传输或化学修饰以增加疏水性。